Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 42, pseudogene (RN7SL42P)
- Target
- RN7SL42P
- Molecular classification
- Other (Pseudogene)
01
Overview
RNA, 7SL, cytoplasmic 42, pseudogene (RN7SL42P) is a processed pseudogene in the human genome. It is related in sequence to the 7SL RNA gene, which encodes the RNA component of the signal recognition particle (SRP) involved in targeting secretory proteins to the endoplasmic reticulum[3][4][5]. Pseudogenes such as RN7SL42P typically arise from duplication or retrotransposition events and are generally not transcribed into functional RNA nor translated into proteins[2][3]. There is currently no evidence that RN7SL42P functions as a therapeutic target or has established roles in disease, drug interaction, or as a biomarker; it is primarily considered a noncoding, nonfunctional genomic sequence. Its designation as a "pseudogene" indicates it is a genetic relic without expected biological activity in most contexts[2][3][4].
- Other names
- RN7SL42P7SL RNA pseudogene 427SL RNA, cytoplasmic 42, pseudogene
02
Biological functions
Other (No direct function; pseudogenes generally do not encode functional products but may sometimes regulate gene expression through RNA-mediated mechanisms)
03
Disease associations
Other (No direct disease role established for RN7SL42P; in general, some pseudogenes can act as competitive endogenous RNAs or regulate parent gene expression, but such functions are not reported for this specific pseudogene[2])
Beyond the preview
Go deeper on RNA, 7SL, cytoplasmic 42, pseudogene (RN7SL42P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 42, pseudogene (RN7SL42P).